COVID-19 and Black, Asian, and Minority Ethnic Communities: A Complex Relationship Without Just Cause

Journal article

Pandemics disrupt clinical trials worldwide, with lasting effects on research. It can severely impact clinical trialists ability to conduct safe and ethically uncompromised trials. Hence, the mounting pressure results in ethically and morally distressing decisions faced by clinical trial professionals during pandemic situations. Whilst clinical trialists attempt to think about preparedness and responses during a pandemic, the need to have an ethical framework that has real-world applicability is imperative. Pandemics are a challenging time for all, however, the safety and access to support for clinical trialists and patients within clinical trials should be at the forefront for their organisations and the government

Authors: Phiri, P; Delanerolle, G; Al-Sudani, A; Rathod, S

• Publication status: Published
• Peer review status: Peer reviewed
• Publisher: JMIR Publications
• Journal: JMIR Public Health and Surveillance
• Volume: 7
• Issue: 2
• Pages: e22581-e22581
• Publication date: 2021-02-01
• DOI: 10.2196/22581
• EISSN: 2369-2960
• ISSN: 2369-2960
• Language: English
• Keywords: Coronavirus disease 2019 (COVID-19); Public health; Environmental health; Pandemic; Mental health; Infectious disease (medical specialty); Medicine; Nursing; Government (linguistics); Political science; Law; Ethnic group; Psychiatry; Disease